rgn-259
Generic: Thymosin beta 4
rgn-259: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| REGENERX BIOPHARMACEUTICALS INC (RGRX) | Phase 2 |
Get deeper analysis on rgn-259
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis